Roncal-Jimenez Carlos A, Rogers Keegan L, Stem Arthur, Wijkstrom Julia, Wernerson Annika, Fox Jacob, Garcia Trabanino Ramon, Brindley Stephen, Garcia Gabriela, Miyazaki Makoto, Miyazaki-Anzai Shinobu, Sasai Fumihiko, Urra Manuel, Cara-Fuentes Gabriel, Sánchez-Lozada L Gabriela, Rodriguez-Iturbe Bernardo, Butler Dawson Jaime, Madero Magdalena, Brown Jared M, Johnson Richard J
Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Am J Physiol Renal Physiol. 2024 Jan 18;326(3):F477-84. doi: 10.1152/ajprenal.00251.2023.
Silica nanoparticles found in sugarcane ash have been postulated to be a toxicant contributing to chronic kidney disease of unknown etiology (CKDu). However, while the administration of manufactured silica nanoparticles is known to cause chronic tubulointerstitial disease in rats, the effect of administering sugarcane ash on kidney pathology remains unknown. Here we investigate whether sugarcane ash can induce CKD in rats. . Sugarcane ash was administered for 13 weeks into the nares of rats (5 mg/day for 5d/week), and blood, urine and kidney tissues were collected at 13 weeks (at the end of ash administration) and in a separate group of rats at 24 weeks (11 weeks after stopping ash administration). Kidney histology was evaluated, and inflammation and fibrosis (collagen deposition) measured. . Sugarcane ash exposure led to the accumulation of silica in the kidneys, lungs, liver and spleen of rats. Mild proteinuria developed although renal function was largely maintained. However, biopsies showed focal glomeruli with segmental glomerulosclerosis, and tubulointerstitial inflammation and fibrosis that tended to worsen even after the ash administration had been stopped. Staining for the lysosomal marker, LAMP-1, showed decreased staining in ash administered rats consistent with lysosomal activation. . Sugarcane ash containing silica nanoparticles can cause CKD in rats.
甘蔗灰中发现的二氧化硅纳米颗粒被认为是导致病因不明的慢性肾脏病(CKDu)的一种有毒物质。然而,虽然已知给予人造二氧化硅纳米颗粒会在大鼠中引起慢性肾小管间质性疾病,但给予甘蔗灰对肾脏病理学的影响仍不清楚。在此,我们研究甘蔗灰是否会在大鼠中诱发慢性肾脏病。将甘蔗灰经大鼠鼻腔给药13周(5毫克/天,每周给药5天),并在13周(给药结束时)收集血液、尿液和肾脏组织,在另一组大鼠24周时(停止给药11周后)收集。对肾脏组织学进行评估,并测量炎症和纤维化(胶原蛋白沉积)情况。接触甘蔗灰导致大鼠肾脏、肺、肝脏和脾脏中二氧化硅的积累。尽管肾功能基本维持,但出现了轻度蛋白尿。然而,活检显示局灶性肾小球伴有节段性肾小球硬化,以及肾小管间质性炎症和纤维化,即使在停止给药后仍有加重趋势。溶酶体标记物LAMP-1染色显示,给药大鼠的染色减少,这与溶酶体激活一致。含有二氧化硅纳米颗粒的甘蔗灰可在大鼠中引起慢性肾脏病。